Purpose: Accurate modeling of rectal complications based on dose-volume histogram (DVH) data are necessary to allow safe dose escalation in radiotherapy of prostate cancer. We applied different equivalent uniform dose (EUD)-based and dose-volume-based normal tissue complication probability (NTCP) models to rectal wall DVHs and follow-up data for 319 prostate cancer patients to identify the dosimetric factors most predictive for Grade > 2 rectal bleeding. Methods and Materials: Data for 319 patients treated at the William Beaumont Hospital with three-dimensional conformal radiotherapy (3D-CRT) under an adaptive radiotherapy protocol were used for this study. The following models were considered: (1) Lyman model and (2) logit-formula with DVH reduced to generalized EUD, (3) serial reconstruction unit (RU) model, (4) Poisson-EUD model, and (5) mean dose-and (6) cutoff dose-logistic regression model. The parameters and their confidence intervals were determined using maximum likelihood estimation. Results: Of the patients, 51 (16.0%) showed Grade 2 or higher bleeding. As assessed qualitatively and quantitatively, the Lyman-and Logit-EUD, serial RU, and Poisson-EUD model fitted the data very well. Rectal wall mean dose did not correlate to Grade 2 or higher bleeding. For the cutoff dose model, the volume receiving > 73.7 Gy showed most significant correlation to bleeding. However, this model fitted the data more poorly than the EUD-based models. Conclusions: Our study clearly confirms a volume effect for late rectal bleeding. This can be described very well by the EUD-like models, of which the serial RU-and Poisson-EUD model can describe the data with only two parameters. Dose-volume-based cutoff-dose models performed worse.
INTRODUCTION
The essential dose-limiting organs in prostate radiotherapy are the bladder and rectum. One of the most relevant side effects that can significantly compromise a patient's quality of life is chronic rectal bleeding.
Conventional external beam radiotherapy (RT) treatment typically does not allow prostate doses beyond 65 to 70 Gy without an unacceptably high risk of rectal toxicity, although higher tumor doses are favorable for improved tumor control. The possibility of dose escalation beyond 70 Gy to the prostate is based on the volume-effect of rectum, i.e., the observation of increased tolerance to high doses if the high dose region is confined to a small volume. Technically, this becomes feasible because of conformal techniques such as three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT), especially when aided by image-guided adaptive approaches.
Safe dose escalation necessitates accurate quantitative modeling of the volume effect based on the detailed dosevolume information provided by modern treatment planning systems. Numerous studies have established evidence of a significant correlation between parameters derived from rectal dose-volume histograms (DVHs) and toxicity (see Refs. 1-4 and references therein). However, only a few publications have quantified the risk of rectal complications in terms of normal tissue complication probability (NTCP) models (5) (6) (7) (8) (9) . Such empiric or semiempiric models parameterize the vast information about inhomogeneous dose distributions and corresponding outcome data from large patient populations into few-parametric models that assign a single probability value to an individual treatment plan. This enables evidence-based ranking of alternative plans in the planning process according to their predicted complication risk. Two important types of NTCP-models can be distinguished. The first are dose-volume-based models, which use a single DVH parameter (e.g., the volume V D irradiated to a certain dose-level D) for ranking plans according to their complication probability. In contrast, EUDlike models define an equivalent uniform dose, EUD ϭ f Ϫ1 ͚͑ i v i f͑D i ͒͒, as surrogate parameter calculated using all bins ( i , D i ) of a DVH, where the form of the (monotonic) function f depends on the model. Besides possible differences in the quality of fit as investigated in this study, it should be mentioned that the choice between dose-volumebased vs. EUD-like models when used for treatment planning, especially IMRT, affects the process of plan optimization (10 -12) .
In this study, we apply one dose-volume-based and five EUD-like NTCP models for chronic rectal bleeding of Grade Ն 2 to a population of 319 prostate cancer patients treated with a 3D-CRT adaptive radiotherapy (ART) technique to doses between 70.2 and 79.2 Gy at the William Beaumont Hospital. This is, so far, the largest published, single-institution patient population studied for fitting of rectal NTCP-models. Thus, this study not only provides valuable information for identification of the superior modeling approaches but also statistically well-based estimates of the corresponding model parameters.
METHODS AND MATERIALS

Patient data
Data for 319 prostate cancer patients treated between 1999 and 2002 at the William Beaumont Hospital were used for this study. The characteristics of this patient population have been described in previous studies (3, 13) . The patients were part of a Phase II dose-escalation study and underwent 3D-CRT with image-guided off-line correction under an ART protocol.
All patients had one pretreatment planning CT scan, daily portal images to determine and correct for setup errors, four additional CT scans during the first week of the treatment used for individual adaptation of the treatment plan, and weekly CT scans in the following to preclude undetected drifts. The (solid) rectum was contoured on the initial CT scan from the anal verge or ischial tuberosities (whichever was higher) to the sacroiliac joints or rectosigmoid junction (whichever was lower). Rectal wall was defined based on the solid rectum contours with 3-to 4-mm wall thickness.
The ART scheme used has been described elsewhere (14, 15) . In short, a four-field box technique with 18 MV photons was used both for the initial treatment plan of the first week and the following adapted plan. In the first week, the patients were treated for a dose of 9 Gy to the target, where the planning target volume (PTV), was generated based on the clinical target volume (CTV), of the initial CT (prostate, or prostate ϩ seminal vesicles) with a population-based margin of 1 cm. For the adapted plan, information from daily portal imaging and the five CT scans available after the first week of treatment were used to estimate setup error and individual prostate mobility, which allowed to define a (generally smaller) patient-specific PTV.
The final dose to the PTV was limited by dose-volume constraints of rectal wall and bladder based on the geometry of the initial planning CT image. For rectal wall these were: (1) D 30% ϭ 75.6 Gy, and (2) D 5% ϭ 82 Gy. The possible dose levels (minimal prostate dose) were chosen under the requirement to meet rectum (and bladder) constraints, and were as follows: 70.2, 72, 73.8, 75.6, 77.4, and 79.2 Gy.
For each patient the dose distributions of the initial and adapted plan were calculated using Pinnacle 6.2b (ADAC Laboratories, Milpitas, CA). An in-house developed software was used to calculate DVHs of the rectal wall. This software used the contours from the initial (planning) CT and calculated the overall dose as sum of initial and adapted (physical) dose distributions. The DVHdose bin size was 0.1 Gy, with volume defined as relative (percentage) volume irradiated.
The rectal toxicity variable regarded in this analysis is chronic rectal bleeding. The follow-up scheme defined examinations at 3-month intervals during the first 2 years, and every 6 months from the second to the fifth year. As mentioned above, this study is based on the patient population analyzed in Vargas et al. (3, 13) . However, for the current study, all patient files were re-examined to improve follow-up time. Complications were graded based on the Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 (Table 1) 
The NTCP models
An NTCP model assigns a complication probability for an organ at risk to a generally inhomogeneous dose distribution. The func- Life-threatening consequences; perforation/dysfunction requiring urgent intervention tional form of such a model can be based on a mechanistic description of biologic processes, or might be designed to result in a phenomenologic fit of the data. The models considered in this work are of the general forms described below.
First, a summary measure , such as the mean dose, an equivalent uniform dose (EUD), or similar, is calculated from the dose distribution. The quantity serves as a ranking function by imposing an order among individual plans according to their complication risk.
Next, a function, NTCP(), which assigns complication probabilities to the values of the summary measure is defined. Such a function is required (1) for continuously mapping to the interval [0, 1], while (2) preserving the ranking imposed by the numerical values of the summary measure. This leads to the class of sigmoidtype (S-shaped) functions, wherein the following probit, logit, Poissonian, and logistic formulae are used.
We applied six different models to our data, where the endpoint was chosen to be chronic rectal bleeding of Grade Ն 2. These models differ in the summary measure used and/or the functional form of the NTCP function as described in the following.
Lyman-EUD model
The most widely used phenomenological approach is the family of Lyman models (16 -20) , which uses the probit function
to map the summary measure to the interval [0, 1] of complication probabilities. This integral essentially yields the error function, where the parameter s is the slope of the sigmoid response curve at the steepest point ϭ 50 , for which the NTCP function predicts 50% complication probability. Usually the slope parameter s is replaced by its inverse m according to s ϭ 1/(m · 50 ). Different DVH reduction schemes have been used for defining the summary measure , such as an effective volume as in the LKB model (18) or an effective dose (21) . In the following, the generalized equivalent uniform dose (22) is used, which defines EUD as Lebesque a-norm of the dose, i.e., in terms of the following power-law relationship:
The sum is calculated over all bins ( i , D i ) of the differential DVH, and a is a parameter associated with the strength of the volume effect for the organ under consideration (range, aʰ [1. . . ϱ ]): For a¡ϱ the EUD is the maximum dose (i.e., no volume effect), whereas for a ϭ 1 Eq. (2) gives the mean dose (large volume effect).
Summarizing, the Lyman-EUD model as used in our study is described by 3 parameters: a, m, and EUD 50 (usually termed D 50 ).
Logit-EUD model
This model also uses the generalized EUD Eq. (2) as summary measure , although it differs from the Lyman-EUD model in the choice of the NTCP function. Here the logit function
is chosen as sigmoid shape function (6, 10) . Its two parameters 50 (i.e., D 50 ) and k are determined by the EUD, which causes a complication rate of 50%, and the slope of the NTCP curve here. Thus, together with the parameter a of the EUD, this model has three parameters.
Serial reconstruction unit model
In contrast to the two previous phenomenologic NTCP models, the serial reconstruction unit model, which has been proposed recently by Alber and Belka (23), arises from certain general assumptions about the biological processes causing normal tissue complications.
The model regards radiation induced complications as the consequence of local failure of dynamic repair processes. As an assumption, the latter is attributed to the finite range of the repair mechanisms, which finds its correlate in the model by the description of finite-sized reconstruction units and their microscopic dose-response. Borrowing analogies from thermodynamics and statistical physics, the authors derive the following expression to describe the macroscopic dose-response in terms of the NTCP for homogeneous irradiation of the partial volume V of an organ with the dose D:
where is an organ specific sensitivity parameter and D 0 is a reference dose. For inhomogeneous dose distributions an equivalent uniform dose, which would give the same macroscopic dose-response when applied homogeneously to the whole organ (V ϭ 1), can be defined as
Consequently, the NTCP function then reads:
Summarizing, the serial reconstruction unit model has the two parameters and D 0 to be fitted. Note that in contrast to the previously described models, which have the volume effect parameter a of the power-law EUD as a third parameter, here the sensitivity parameter is inherently coupled to the same value in the EUD and NTCP function.
Poisson-EUD model
Similarly to the serial reconstruction unit model, this model uses mechanistic concepts to describe predominantly serial tissue doseresponse. Assuming that complication is a consequence of local dose-response of noninteracting subunits, the following NTCPfunction can be derived based on Poissonian statistics (24) :
with a reference dose D 0 (or a dose D 50 causing 50% complication probability) and a volume-effect (steepness) parameter a. The EUD is given by Eq. (2), where, according to this model, the exponent of EUD and the steepness parameter of the NTCP function have the same value. Thus, unlike the Lyman-and Logit-EUD models, the Poisson-EUD model has only two parameters.
Mean dose logistic regression model
An association of the rectal mean dose with chronic rectal bleeding has been reported by some authors (7, 8) . To test for such an association based on our data, we used logistic regression as a standard method from statistics for this purpose. In terms of the general NTCP model scheme presented above, here the NTCP function is given by the two-parametric logistic function 
Cutoff dose logistic regression model
In classical, i.e., nonbiological treatment planning approaches, dose limitation to organs at risk (OAR) is usually implemented in terms of dose-volume constraints. For a given treatment-technique, the most relevant dose level(s) predictive for toxicity can be determined by retrospectively fitting a sigmoid type NTCP function to outcome data of a patient population.
In this phenomenological approach, the summary measure is given by the proportion 
Fitting procedure
The method of choice for fitting such models to sparse, dichotomous response data (0/1, if patient shows bleeding of Grade Ͻ 2 or Ն 2, respectively) is maximum likelihood estimation (Jackson et al. (25) and references therein; see also Ref. 6) . In this method the optimal model parameters are determined such as to maximize the probability of occurrence of the observed data, which is given by the so-called likelihood function L. Because of its smallness, numerically this is usually implemented as maximization of the natural logarithm ln(L), the LogLikelihood (LL). In our implementation, the software package Mathematica version 5.0 (Wolfram Research Inc., Champaign, IL) was used. To reduce calculation time, the DVH discretization was changed to 0.5 Gy when fitting the Lyman-, Logit-, Poisson-EUD, and serial reconstruction unit models.
Uncertainties of the model parameters were assessed using the variance-covariance matrix of the parameters calculated around the maximum of LL as described in (25) . The 68% confidence intervals for the parameters can be estimated by the square root of the diagonal elements.
The goodness of fit of each individual model has been quantified in two ways. The first method follows Jackson et al. (25) . If the actual (maximized) value of the LL for the NTCP model fitted to the observed patient population is denoted by LL obs , the probability P of obtaining a value smaller than LL obs (i.e., a worse fitting model) purely by chance can be assessed based on the statistical distribution of LL. This can be obtained from analytical formulae for the mean ͗LL͘ and variance S LL (see Eq. A3 and A4 in Jackson et al.) under the assumption of a normally distributed LL. If this probability turns out to be too large, the model "overfits" the data; if it is too small, the model does not fit the data well. According to Rancati et al. (6) values between 30% and 70% indicate a satisfactory fit.
Additionally, a chi-square goodness-of-fit test was performed for each model: A histogram of the observed patient data was calculated, and the resulting group complication rates f i (obs) were compared with the corresponding rates f i (fit) predicted by the respective NTCP model by determining 
Intermodel comparison: Akaike information criterion
A widely used measure allowing to compare competing models is the AIC (26, 27) ; see also (7) . Generally, for fits of different models to a given dataset a larger likelihood value indicates a better fit to the data. The AIC quantifies the tradeoff between the model's quality of fit (associated with the likelihood value) and its complexity (expressed by the number of model parameters n), and is defined as AIC ϭ Ϫ2LL ϩ 2n. Models with smaller AIC values are considered to provide a better (in the sense of more efficient) fit to the data than models with larger AIC.
RESULTS
Of the 319 patients, 45, 5, and 1 (14.1%, 1.6%, and 0.3%) showed chronic rectal bleeding of Grade 2, 3, and 4, respectively. Thus, altogether 51 patients (16.0%) showed chronic rectal bleeding of Grade Ն 2, which is the endpoint for the following model fits.
EUD-based models, mean dose model
Parameter estimates and their 68% CIs for the Lyman-, Logit-, Poisson-EUD, and serial reconstrunction unit model are given in Table 2 . The plots of the corresponding NTCPcurves are shown in Fig. 1a to 1d . As obvious in these plots by comparison with the observed complication rates, all four models fit the data very well. Quantitatively, this is manifest by the small values of 2 : For example, the fit of the serial reconstruction unit model (Fig. 1c) resulted in a 2 of 0.03, where the upper limit of 2 for an acceptable fit is 5.99 according to Chi-square statistics (2 degrees of freedom; ␣ ϭ 0.05). As described later here, the goodness of fit was also determined based on the LL, ͗LL͘ and S LL . These values together with the resulting probability P of obtaining a smaller LL are given in Table 2 . Again, for all four models P indicates acceptable fits.
Concerning the mean dose logistic regression model, it turns out that D mean does not significantly correlate to chronic rectal bleeding of Grade Ն 2 (p ϭ 0.11). The worse fit quality of this model in comparison with the four abovementioned EUD-based models is also expressed by its significantly lower LL value (Table 2) . Thus, this model is not considered further in this study. Figure 2a shows the LL values of different logistic regression model fits when varying the cutoff dose D c . For all dose levels in the range D c ϳ 50 to 80 Gy, a significant correlation (␣ Ͻ 0.05) of the relative volume irradiated with doses Ն D c and chronic rectal bleeding of Grade Ն 2 was found for our patient population. The curve has maxima at D c ϭ 73.7 Gy and 79.6 Gy. Figure 2b depicts the model fit for D c ϭ 73.7 Gy: As obvious, the fit quality is slightly worse than for the EUD-models. However, both the value of P in Table 2 and a 2 of 1.06 (upper limit according to Chi-square statistics [1 degree of freedom, ␣ ϭ 0.05]: 3.84) show that the fit is acceptable. Formally, this is also the case for the model with D c ϭ 79.6 Gy (plot not shown; 2 ϭ 2.24 Ͻ 3.84). However, as only a part of our patient population receives doses above 79.6 Gy to nonvanishing volumes of rectal wall, the distribution of the summary measure V 79.6 Gy itself is strongly shifted to small values, thereby compromising the statistical strength of the patient dataset in the region of larger V 79.6 Gy .
Cutoff dose model
Comparison of the models
Both visually from Fig. 1 and according to the LL values in Table 3 , the four EUD-based NTCP models fit the data of chronic rectal bleeding of Grade Ն 2 equally well. However, as the Akaike information criterion shows, both twoparametric NTCP models (serial reconstruction unit model and Poisson-EUD model) have the lowest AIC-values (Table 3) and thus, can be considered to fit the data most efficiently.
Compared with these models, the AIC-values of the two cutoff-dose models (D c ϭ 73.7 Gy and 79.6 Gy) are considerably larger, which is caused by both the smaller LL values (indicating worse fit quality itself) and the larger number of model parameters. Thus the EUD-based models provide a quantitatively better and more efficient description of our dataset.
DISCUSSION AND CONCLUSIONS
In this study, six dose-volume-based or EUD-like NTCP models were fitted to late rectal bleeding data of a large, consistently treated patient population (319 patients), thereby aiming to identify the most accurate approach for quantifying the risk of chronic rectal bleeding based on planned dose distributions of rectum and allowing statistically robust estimation of the corresponding model parameters.
Our results clearly confirm the volume effect for chronic rectal bleeding of Grade 2 or worse. Quantitatively, this can be described very well with the four EUD-like models, where the serial reconstruction unit and the Poisson-EUD model fitted the data most efficiently according to the smallest AIC values, as they need only two parameters to describe the dataset. Thus according to our data, these two models can be considered to provide the most concise approach to quantifying the risk of chronic rectal bleeding of Grade 2 or worse. The cutoff-dose model, a directly dose-volume based model, generally fitted the data worse, but still found significant correlation of rectal wall relative volume above single cutoff-dose levels D c in the range ϳ 50 to 80 Gy (most significant for D c ϭ 73.7 and 79.6 Gy) for our patient population. Mean dose did not correlate to late rectal bleeding of Grade Ն 2.
For the three models incorporating the power-law EUD Eq. (2), i.e., the Lyman-, Logit-, and Poisson-EUD model, the parameter describing the volume effect was found to be in the order of a Ϸ 12 ( Table 2) . Accounting for uncertainties in parameter estimation, this is consistent to Burman et al. (5) , who found n Ϸ 0.12 (different definition of volume effect parameter: a ϭ 1/n, i.e., a ϭ 8.3). It is also in agreement with the data published by Skwarchuk et al. (28) which yield a ϭ 10.3 (fit based on Fig. 3 of the cited paper) . Because of the ART-protocol used, which defined different prescription dose levels depending on individual organ geometry and mobility, the patient population shows a wide range of DVH shapes and thus large variability of dosevolume combinations, which is advantageous for robust fitting of NTCP models. However, possible statistical biases are introduced by the treatment technique and specific characteristics of the patient population itself. This is indeed the case as becomes most evident for the results of the cutoff-dose model, Gy with toxicity in contradiction to our findings. This is likely because of differences in the treatment technique (6-field 3D-CRT vs. 4-field box in combination with 6-field 3D-CRT boost), which induces specific correlations between dose-bins. Thus an important conclusion is that results of DVH-based models like the cutoff-dose model are superimposed by characteristics of the treatment technique and patient population, which compromises inferences about radiobiological effects and extrapolability of results gained from a certain treatment technique to others.
With regard to the mean dose model, our results are in contrast to the studies of Zapatero et al. (8) , Tucker et al. (7) , who found a correlation of mean dose and chronic rectal bleeding of Grade Ն 2. Again, this might be because of differences in the treatment technique or the grading scheme used; in this context, it should be mentioned that Grade Ն 3 bleeding correlated to mean dose for our population (p ϭ 0.045; data not shown).
With respect to the magnitude of the volume effect for rectum, our results can be compared with values published for other organs (5): Lung (a Ϸ 1.1) and liver (a Ϸ 3.1) are typical organs with a large volume effect, while e.g., spinal cord shows only a small volume effect (a Ϸ 20.0). Thus, for our Abbreviations: EUD ϭ equivalent uniform dose; LL ϭ LogLikelihood; n ϭ number of model parameters; RU ϭ reconstruction unit.
* Model is not significant (p Ͼ 0.05).
data, the EUD-like models suggest a rather small volume effect of rectal bleeding (a Ϸ 13.5 for the Poisson-EUD model, Table  2 ). As illustration of this, a plan should not have more than 2.4% (1.7%) of rectal volume irradiated with 80 Gy (82 Gy) to have the same EUD (and thus same NTCP) as an otherwise identical plan with 72 Gy to 10% of the volume. If the presented EUD-based models are used for dose optimization, e.g., for IMRT dose escalation, it is always preferrable to err toward smaller volume effects. In consequence, a EUD-based optimization of prostate RT with the parameters derived here will severely penalize high dose regions in the rectum, perhaps for some patients to an extent that prevents satisfying PTV coverage. Hence, the data suggest that safe dose escalation to the prostate can be achieved only by image guided and adaptive strategies to reduce the extent of the PTV.
